Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Incorporated (CORT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $11.6B; returns 1 day -20.1%, 1 week -22.1%, 1 year +17.6%.

Corcept Therapeutics Incorporated is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines that modulate cortisol activity at the glucocorticoid receptor (GR) to treat severe metabolic, psychiatric, and oncologic diseases.

Groups CORT belongs to

• Shrinking Share Count
• Biotechnology
• Commercial Stage Biotech
• Biopharmaceutical
• Healthcare
• Metabolic Disorders
• Pharmaceuticals
• Oncology
• Endocrinology
• Rare Diseases
• Life Sciences

CORT financial model: income statement, cash flow and balance sheet